OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial

HTML

Year: 1999
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Critical Care Medicine
DOI: 10.1097/00003246-199911000-00004
Authors: Howard L. Corwin, Andrew Gettinger, Robert M. Rodriguez, Ronald G. Pearl, K. Dean Gubler, Christopher Enny, Theodore Colton, Michael J. Corwin
Institutions: Dartmouth–Hitchcock Medical Center, Karel de Grote Hogeschool, Boston University, Naval Medical Center San Diego, Stanford Medicine, Stanford University
Language: English

Topic: Erythropoietin and Anemia Treatment
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: recombinant human erythropoietin, red blood cell transfusion, critically ill patients, intensive care unit, hematocrit, anemia, mortality, adverse events, subcutaneous administration, hematopoietic growth factors, mortality reduction, hematocrit monitoring
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1970827178
FWCI: 10.59
Cites: 15
Cited by: 362
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms